KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 176 filers reported holding KITE PHARMA INC in Q1 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $10,668,000 | +85.2% | 59,331 | +6.8% | 0.02% | +76.9% |
| Q2 2017 | $5,760,000 | +55.8% | 55,560 | +18.0% | 0.01% | +44.4% |
| Q1 2017 | $3,696,000 | +84.3% | 47,094 | +5.3% | 0.01% | +80.0% |
| Q4 2016 | $2,005,000 | -14.4% | 44,719 | +6.6% | 0.01% | -16.7% |
| Q3 2016 | $2,343,000 | +20.3% | 41,939 | +7.7% | 0.01% | 0.0% |
| Q2 2016 | $1,947,000 | +30.1% | 38,948 | +19.5% | 0.01% | +20.0% |
| Q1 2016 | $1,496,000 | -15.6% | 32,583 | +13.3% | 0.01% | -16.7% |
| Q4 2015 | $1,773,000 | +21.9% | 28,768 | +10.2% | 0.01% | +20.0% |
| Q3 2015 | $1,454,000 | -5.0% | 26,108 | +4.0% | 0.01% | 0.0% |
| Q2 2015 | $1,531,000 | +180.4% | 25,115 | +165.5% | 0.01% | +150.0% |
| Q1 2015 | $546,000 | +36.5% | 9,460 | +36.4% | 0.00% | +100.0% |
| Q4 2014 | $400,000 | – | 6,935 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $135,991,000 | 55.96% |
| Lamond Capital Partners LLC | 365,900 | $21,101,000 | 13.82% |
| EcoR1 Capital, LLC | 438,400 | $25,283,000 | 12.80% |
| DSAM Partners (London) Ltd | 399,571 | $23,043,000 | 6.08% |
| Silver Rock Financial LLC | 476,563 | $27,483,000 | 5.08% |
| Cormorant Asset Management, LP | 255,000 | $14,706,000 | 2.27% |
| Opaleye Management Inc. | 76,000 | $4,383,000 | 2.22% |
| Ghost Tree Capital, LLC | 60,000 | $3,460,000 | 1.66% |
| SPHERA FUNDS MANAGEMENT LTD. | 110,970 | $6,400,000 | 1.09% |
| PURA VIDA INVESTMENTS, LLC | 44,250 | $2,552,000 | 0.94% |